Skip to main content

Table 1 Patients’ characteristics

From: Serum microRNA-1233 is a specific biomarker for diagnosing acute pulmonary embolism

n

30

Age (mean ± SD)

62 ± 14

Male

17/30 (57 %)

CTA confirmed central PE (pulmonary trunk, main pulmonary arteries)

100 %

Risk stratefication (PE-related early mortality rate)

 High (>15 %)

4/30 (13 %)

 Intermediate (3–15 %)

15/30 (50 %)

 Low (<1 %)

11/30 (37 %)

Symptoms

 Dyspnoea

24/30 (81 %)

 Chest pain

10/30 (33 %)

 Cough

3/30 (10 %)

 Syncope

3/30 (10 %)

 Haemoptysis

2/30 (7 %)

 Collaps with subsequent CPR

4/30 (13 %)

Idiopathic DVT/PE

13/30 (43 %)

Secondary DVT/PE

 Malignancy

4/30 (13 %)

 Post surgery

4/30 (13 %)

 Immobilisation

2/30 (7 %)

 Thrombophilia

1/30 (3 %)

 Previous DVT/PE

2/30 (7 %)

 Oral contraceptive therapy

2/30 (7 %)

 Obesity (BMI ≥ 30 kg/m2)

12/30 (40 %)

US confirmed DVT

25/30 (83 %)

  1. Characteristics of acute pulmonary embolism (PE) patients at the time of the emergency room presentation (1st day)
  2. CTA computed tomography (pulmonary) angiography, CPR cardiopulmonary resuscitation, DVT deep vein thrombosis, BMI body mass index, US ultrasound, SD standard deviation